Clinical trial
Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
NCT02157987 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective Dose
- Lead sponsor
- University Hospital, Caen
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 15, 2014
- Completion date
- December 8, 2021
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.